PROGLYCEM 50 MG/ML ORAL SUSP
FDA nonproprietary name: diazoxide
For 30 mL
Pharmacies pay
$494.48 filed
30 × $16.4826 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$383.22 filed
30 × $12.77401 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.77× estimated
Medicare paid 23% less than pharmacies pay.
Part D averages every strength and form sold under “Proglycem” / “Diazoxide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$573.65 estimated
$494.48 + $74.17 (15%) + $5.00 fee per fill = $573.65
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
PROGLYCEM 50 MG/ML ORAL SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as diazoxide, under the trade name “Proglycem”.
FDA gives its dosage form as suspension and its route as oral.
The labeler, the company named on the label, is Teva Pharmaceuticals USA, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00575-6200-30.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $494.48 for 30 mL (30 × $16.4826 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $7.3764 per ML filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes
The NDC
- 00575-6200-30 · Teva Pharmaceuticals USA, Inc. · $16.4826 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name diazoxide with PROGLYCEM 50 MG/ML ORAL SUSP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DIAZOXIDE 50 MG/ML ORAL SUSP | $7.3764 per ML filed | $6.80068 per ML filed |
| PROGLYCEM 50 MG/ML ORAL SUSP this page | $16.4826 per ML filed | $12.77401 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $383.22 for 30 mL, at an average of $12.77401 per ML in 2024 (2024-01-01 to 2024-12-31) for “Proglycem” and “Diazoxide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 49 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 mL? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: DIAZOXIDE 50 MG/ML ORAL SUSP. Ask your pharmacist or prescriber; do not switch on your own.
- How much is in the package I am getting? This page uses 30 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for PROGLYCEM 50 MG/ML ORAL SUSP labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Proglycem / Diazoxide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 30 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 30 mL in one package for this product’s NDC (“1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 30 ML. Change it to match your prescription.